RELATED REPORTS
Tags: acute myeloid leukemiaAMLatra-iceatraicebloodblood cancerblood marrowblood samplecancercancer prognosischemotherapyconsolidationcumulative incidencecumulative incidence of relapsegenetic mutationgetuzumabgetuzumab ozogamicinhematologyinductionleukemiamutationnpm1npm1mutnucleophosmin1 mutated acute myeloid leukemiaoncologyprognostic factorprognostic testrelapse rateresidual diseaseresidual disease negativitytreatment cycles
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)






